Cliff Asness’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$89.7K Buy
+52,448
New +$107K ﹤0.01% 3993
2025
Q4
– Sell
-10,660
Closed -$5.31K – 3605
2025
Q3
$5.31K Sell
10,660
-136,508
-93% -$73.6K ﹤0.01% 3456
2025
Q2
$82.2K Buy
147,168
+36,089
+32% +$19.4K ﹤0.01% 3211
2025
Q1
$52.9K Buy
111,079
+86,875
+359% +$65.3K ﹤0.01% 3079
2024
Q4
$24.4K Buy
24,204
+3,343
+16% +$4.55K ﹤0.01% 2841
2024
Q3
$35.7K Buy
+20,861
New +$40.9K ﹤0.01% 2723

Other funds holding IPSC

Cliff Asness's IPSC Position: Q3 2026 in Review

Cliff Asness opened a new position in Century Therapeutics (IPSC) in Q3 2026: 52,448 shares worth $89.7K. The stake represents ﹤0.01% of the portfolio and ranks #3993 among its holdings. This is a return to the name: Cliff Asness previously reported a position in IPSC as recently as Q3 2025.

Cliff Asness first reported a position in IPSC in Q3 2024 and has held it in 6 quarters since. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Cliff Asness held 52,448 shares of Century Therapeutics worth $89.7K as of Q3 2026.
  • Century Therapeutics was a new Cliff Asness position in Q3 2026.
  • Century Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3993 holding.
  • Cliff Asness first reported a position in Century Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.